Literature DB >> 30840848

Relaxin in liver transplantation: A personal perspective.

Shoichi Kageyama1, Kojiro Nakamura1, Jerzy W Kupiec-Weglinski2.   

Abstract

Entities:  

Keywords:  Anti apoptosis; Ischemia reperfusion injury; Liver transplantation

Mesh：

Substances：

Year:  2019        PMID： 30840848      PMCID： PMC7417179          DOI： 10.1016/j.mce.2019.02.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN： 0303-7207            Impact factor:   4.102


× No keyword cloud information.
  16 in total

1.  The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.

Authors:  Peter J Raubenheimer; Elizabeth A Young; Ruth Andrew; Jonathan R Seckl
Journal:  Clin Endocrinol (Oxf)       Date:  2006-07       Impact factor: 3.478

Review 2.  Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia-reperfusion injury and surgical stress response in patients undergoing liver resection.

Authors:  L A Orci; C Toso; G Mentha; P Morel; P E Majno
Journal:  Br J Surg       Date:  2013-01-21       Impact factor: 6.939

Review 3.  Major challenges limiting liver transplantation in the United States.

Authors:  J A Wertheim; H Petrowsky; S Saab; J W Kupiec-Weglinski; R W Busuttil
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

Review 4.  Glucocorticoids use in kidney transplant setting.

Authors:  Débora Dias De Lucena; Érika Bevilaqua Rangel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-10-05       Impact factor: 4.481

5.  Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway.

Authors:  Giulia Boccalini; Chiara Sassoli; Lucia Formigli; Daniele Bani; Silvia Nistri
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

6.  Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside.

Authors:  Shoichi Kageyama; Kojiro Nakamura; Takehiro Fujii; Bibo Ke; Rebecca A Sosa; Elaine F Reed; Nakul Datta; Ali Zarrinpar; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

7.  Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.

Authors:  Jonathan A Fallowfield; Annette L Hayden; Victoria K Snowdon; Rebecca L Aucott; Ben M Stutchfield; Damian J Mole; Antonella Pellicoro; Timothy T Gordon-Walker; Alexander Henke; Joerg Schrader; Palak J Trivedi; Marc Princivalle; Stuart J Forbes; Jane E Collins; John P Iredale
Journal:  Hepatology       Date:  2014-03-03       Impact factor: 17.425

8.  Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist.

Authors:  Thomas Dschietzig; Cornelia Bartsch; Verena Stangl; Gert Baumann; Karl Stangl
Journal:  FASEB J       Date:  2004-08-02       Impact factor: 5.191

9.  Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.

Authors:  Duncan M Gascoyne; Robert M Kypta; Maria d M Vivanco
Journal:  J Biol Chem       Date:  2003-03-12       Impact factor: 5.157

10.  Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.

Authors:  Chiara Sassoli; Flaminia Chellini; Alessandro Pini; Alessia Tani; Silvia Nistri; Daniele Nosi; Sandra Zecchi-Orlandini; Daniele Bani; Lucia Formigli
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240
View more
  1 in total

Review 1.  Pharmacological Benefits and Risk of Using Hormones in Organ Perfusion and Preservation Solutions in the Aspect of Minimizing Hepatic Ischemia-Reperfusion Injury during Storage.

Authors:  Aneta Ostróżka-Cieślik; Barbara Dolińska
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.